Clinical trial
Comparison of the Efficacy and Safety of Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Asthma Presenting at the Emergency Room for Moderate Exacerbation
NCT04705727 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal Creteil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy and Safety of Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Asthma Presenting at the Emergency Room for Moderate Exacerbation
- Lead sponsor
- Centre Hospitalier Intercommunal Creteil
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- August 23, 2021
- Completion date
- June 23, 2023
- Enrollment
- 102 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
asthma in children